DPCD
(Deleted in Primary Ciliary Dyskinesia Homolog (DPCD))
Protein Region
N-Term
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-RP11-529I10.4 antibody (Catalog #: ARP55256_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
DPCD
(Deleted in Primary Ciliary Dyskinesia Homolog (DPCD))
Synonyme
RP11-529I10.4 Peptide, zgc:153412 Peptide, rp11-529i10.4 Peptide, 5330431N19Rik Peptide, Ndac Peptide, RGD1307648 Peptide, deleted in primary ciliary dyskinesia homolog (mouse) Peptide, deleted in a mouse model of primary ciliary dyskinesia S homeolog Peptide, deleted in primary ciliary dyskinesia Peptide, DPCD Peptide, dpcd Peptide, dpcd.S Peptide, Dpcd Peptide
Hintergrund
RP11-529I10.4 (DPCD) belongs to the DPCD family. It may play a role in the formation or function of ciliated cells. Deletion of the DPCD gene may be a cause of primary ciliary dyskinesia (PCD).